Shareholding for the Period Ended December 31, 2015
Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here09-02-2016
Shareholding for the Period Ended December 31, 2015
Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click hereNomination and Remuneration Committee Meeting on Feb 10, 2016
Themis Medicare Ltd has informed BSE that at the Nomination and Remuneration Committee Meeting to be held on February 10, 2016 a proposal for issuance of ESOPs to eligible employees will be considered and recommended to the Board for approval.Board Intimation for Results & Closure of Trading Window
Themis Medicare Ltd has informed BSE that the meeting of the Board of Directors of the Company is schedule to be held on February 10, 2016, inter alia, to consider, approval of Unaudited Financial Result for the quarter / nine months ended December 31, 2015.Further the Trading Window in respect of the Company's Securities shall remain closed for all Directors/Officer/Designated Employees of the Company from the opening of the trading hours...Themis Bioscience appoint Dr Philippe Dro and Dr Christian Mandl
The appointment follows in the wake of the successful completion of a phase I clinical trial of the company's Chikungunya vaccineStatement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Themis Medicare Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Financial Results & Limited Review for Sept 30, 2015 (Standalone)
Themis Medicare Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015.Themis Medicare hits record high on strong Q2 results
Post Q2 results, the stock zoomed 40% from Rs 268 to Rs 376 compared to 3% decline in S&P BSE Sensex.Results Press Release
Themis Medicare Ltd has submitted to BSE a copy of Results Press Release for the period ended September 30, 2015.Outcome of Board Meeting
Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 05, 2015, inter alia, has approved allotment of 18900 Equity Shares of Rs. 10/- each fully paid up to employees who have exercised their option under THEMIS MEDICARE ESOS, 2012.Further the Board of Directors has renamed the Audit Committee as Audit & Risk Management Committee.Financial Results & Limited Review Report for Sept 30, 2015
Themis Medicare Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015.